|Articles|November 1, 2001
- Applied Clinical Trials-11-01-2001
- Volume 8
- Issue 11
Stephen Senn
Moving between the UK and Switzerland, and between academia and industry has given Editorial Advisory Board member and statistician Stephen Senn a well-rounded view of pharmaceutical development.
Advertisement
Articles in this issue
about 24 years ago
Enterprise Services Automation Softwareabout 24 years ago
Bridging the Gap Between IT and Clinical Operationsabout 24 years ago
Wireless Data: Challenges in the New New Economyabout 24 years ago
Educating Investigators to Understand When to Break the Blindabout 24 years ago
Bioterrorism and Research Policyabout 24 years ago
Thinking Ahead on Clinical ResearchNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Outlines New Superiority Standard for Future CAR-T Approvals
2
ACT Brief: New CAR-T Trial Requirements, Pfizer Advances Oral GLP-1 Strategy, and Kisqali Shows Durable Long-Term Control
3
Noteworthy Focus Points That Help Differentiate Anti-Obesity Drug Development Strategies in a Rapidly Evolving and Expanding R&D Landscape
4
Accelerating Clinical Trial Timelines with AI
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
